SGFY has been the subject of a number of other reports. Piper Sandler raised their price objective on shares of Signify Health from $27.00 to $32.00 and gave the company an overweight rating in a research note on Monday, June 6th. Robert W. Baird raised shares of Signify Health from a neutral rating to an outperform rating and reduced their price target for the company from $19.00 to $16.00 in a research report on Monday, May 16th. Deutsche Bank Aktiengesellschaft lowered their price objective on Signify Health from $29.00 to $26.00 in a research report on Friday, May 6th. Finally, Guggenheim initiated coverage on Signify Health in a report on Tuesday, March 29th. They issued a buy rating and a $36.00 target price for the company. One analyst has rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of Moderate Buy and a consensus price target of $25.13.
Signify Health Price Performance
Shares of SGFY stock opened at $16.41 on Wednesday. The business’s fifty day moving average is $14.05 and its 200 day moving average is $14.39. The company has a quick ratio of 4.82, a current ratio of 4.82 and a debt-to-equity ratio of 0.22. The stock has a market cap of $3.83 billion, a price-to-earnings ratio of 86.37 and a beta of 1.08. Signify Health has a twelve month low of $10.70 and a twelve month high of $28.68.
Signify Health (NYSE:SGFY – Get Rating) last released its earnings results on Wednesday, May 4th. The company reported $0.11 earnings per share for the quarter, topping analysts’ consensus estimates of $0.03 by $0.08. Signify Health had a net margin of 3.95% and a return on equity of 3.22%. The firm had revenue of $216.50 million for the quarter, compared to the consensus estimate of $213.21 million. During the same period in the prior year, the firm earned $0.20 EPS. The company’s revenue was up 20.3% compared to the same quarter last year. Research analysts expect that Signify Health will post 0.11 EPS for the current fiscal year.
Insider Buying and Selling
In other Signify Health news, insider Steve Senneff purchased 2,500 shares of Signify Health stock in a transaction dated Monday, May 9th. The stock was purchased at an average price of $11.75 per share, with a total value of $29,375.00. Following the transaction, the insider now directly owns 217,587 shares of the company’s stock, valued at $2,556,647.25. The purchase was disclosed in a document filed with the SEC, which is available through this link. In related news, CEO Bradford Kyle Armbrester acquired 8,320 shares of the stock in a transaction dated Monday, May 9th. The shares were purchased at an average cost of $11.77 per share, with a total value of $97,926.40. Following the transaction, the chief executive officer now directly owns 92,693 shares in the company, valued at $1,090,996.61. The acquisition was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Steve Senneff bought 2,500 shares of Signify Health stock in a transaction that occurred on Monday, May 9th. The stock was purchased at an average cost of $11.75 per share, with a total value of $29,375.00. Following the completion of the acquisition, the insider now directly owns 217,587 shares in the company, valued at approximately $2,556,647.25. The disclosure for this purchase can be found here. Insiders bought 20,820 shares of company stock valued at $252,801 over the last 90 days. Company insiders own 8.02% of the company’s stock.
Hedge Funds Weigh In On Signify Health
A number of hedge funds have recently modified their holdings of the company. Meeder Asset Management Inc. purchased a new stake in shares of Signify Health during the first quarter worth about $28,000. Manchester Capital Management LLC bought a new position in Signify Health in the 1st quarter worth approximately $30,000. Advisor Group Holdings Inc. grew its holdings in Signify Health by 293.9% during the 1st quarter. Advisor Group Holdings Inc. now owns 2,198 shares of the company’s stock valued at $40,000 after buying an additional 1,640 shares in the last quarter. Federated Hermes Inc. bought a new stake in shares of Signify Health during the first quarter valued at approximately $42,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank lifted its holdings in shares of Signify Health by 349.1% in the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 10,684 shares of the company’s stock worth $152,000 after buying an additional 8,305 shares in the last quarter.
About Signify Health
Signify Health, Inc operates a healthcare platform that utilizes analytics, technology, and healthcare provider networks in the United States. The company operates through Home & Community Services and Episodes of Care Services segments. The Home & Community Services segment offers health evaluations performed within the patient’s home or at a healthcare provider facility primarily to Medicare Advantage health plans; diagnostic screening and other ancillary services; and services to address healthcare concerns related to social determinants of health.
Receive News & Ratings for Signify Health Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Signify Health and related companies with MarketBeat.com’s FREE daily email newsletter.